You are here: Industry Insights > oncology

News List

Novartis oncology CEO quits after less than a year pharmaphorum
December 21, 2018
Novartis has appointed Susanne Schaffert to lead its oncology division after incumbent CEO Liz Barrett decided to leave for another job.
Novartis Announces New CEO of Oncology Business Unit americanpharmaceuticalreview
December 21, 2018
Novartis announced Susanne Schaffert, Ph.D., currently President, Advanced Accelerator Applications (AAA), a Novartis company, has been appointed CEO Novartis Oncology.....
Lilly lays out sunny 2019 forecast driven by growth of new diabetes, psoriasis and cancer drugs fiercepharma
December 20, 2018
Shares of Eli Lilly were up nearly 3% in premarket trading on Wednesday after the company provided a revenue and profit forecast for next year that beat analysts’ expectations.
Pharma R&D productivity hits new low amid rising costs pharmaphorum
December 20, 2018
Returns on pharma R&D investment are at a nine-year low, and the cost of developing a drug has nearly doubled since 2010, according to Deloitte’s yearly assessment of the industry’s pipeline productivity.
Long-awaited M&A boom will hit biopharma in 2019 despite persistent worries, prognosticators predict fiercepharma
December 20, 2018
When Congress passed a business-friendly tax package last year, pharma prognosticators predicted 2018 would be the year that mergers and acquisitions in the sector would finally gain steam. They were wrong.
Innovent buys Chinese rights to Incyte drugs for $40M upfront fiercebiotech
December 18, 2018
Innovent Biologics has bagged the Chinese rights to three clinical-phase oncology and hematology drugs in development at Incyte.
Pfizer receives positive CHMP opinion for oncology biosimilar, ZIRABEV™ (bevacizumab) worldpharmanews
December 17, 2018
Pfizer announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending marketing authorization for ZIRABEV™ (bevacizumab).
Oxybutynin improves quality of life for breast cancer survivors europeanpharmaceuticalreview
December 10, 2018
Oxybutynin could help breast cancer survivors who are affected by increased hot flushes through cancer treatment, improving their quality of life…
GSK reaches agreement to acquire TESARO, an oncology focused biopharmaceutical company worldpharmanews
December 07, 2018
The proposed transaction will significantly strengthen GSK's pharmaceutical business, accelerating the build of GSK's pipeline and commercial capability in oncology.
EUSA Pharma Appoints President of US Operations americanpharmaceuticalreview
December 06, 2018
EUSA Pharma, a global biopharmaceutical company with a focus on oncology and rare disease, has announced the appointment of Jeffrey S. Hackman as President.....

Previous page 1 2 3 4 5 6 7 8 9 10 ... 18 19 Next page